AZN logo

AstraZeneca (AZN) Operating expenses

annual operating expenses:

$33.86B+$5.04B(+17.49%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual total operating expenses is $33.86 billion, with the most recent change of +$5.04 billion (+17.49%) on December 31, 2024.
  • During the last 3 years, AZN annual operating expenses has risen by +$8.74 billion (+34.81%).
  • AZN annual operating expenses is now at all-time high.

Performance

AZN Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

quarterly operating expenses:

$7.67B-$2.46B(-24.25%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly total operating expenses is $7.67 billion, with the most recent change of -$2.46 billion (-24.25%) on March 31, 2025.
  • Over the past year, AZN quarterly operating expenses has increased by +$327.00 million (+4.45%).
  • AZN quarterly operating expenses is now -24.25% below its all-time high of $10.13 billion, reached on December 31, 2024.

Performance

AZN quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

AZN Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.5%+4.5%
3 y3 years+34.8%+9.6%
5 y5 years+91.0%+106.6%

AZN Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+34.8%-24.3%+19.9%
5 y5-yearat high+94.6%-24.3%+115.5%
alltimeall timeat high+565.3%-24.3%+1011.4%

AZN Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$7.67B(-24.3%)
Dec 2024
$33.86B(+17.5%)
$10.13B(+20.9%)
Sep 2024
-
$8.38B(+4.6%)
Jun 2024
-
$8.01B(+9.0%)
Mar 2024
-
$7.35B(-13.4%)
Dec 2023
$28.82B(+5.0%)
$8.48B(+14.0%)
Sep 2023
-
$7.44B(+6.3%)
Jun 2023
-
$7.00B(+5.0%)
Mar 2023
-
$6.67B(+4.2%)
Dec 2022
$27.45B(+9.3%)
$6.40B(-5.3%)
Sep 2022
-
$6.75B(-6.6%)
Jun 2022
-
$7.23B(+3.3%)
Mar 2022
-
$7.00B(-21.1%)
Dec 2021
$25.12B(+44.3%)
$8.87B(+14.0%)
Sep 2021
-
$7.78B(+58.8%)
Jun 2021
-
$4.90B(+37.7%)
Mar 2021
-
$3.56B(-36.9%)
Dec 2020
$17.40B(-1.8%)
$5.64B(+39.8%)
Sep 2020
-
$4.04B(+0.7%)
Jun 2020
-
$4.01B(+7.9%)
Mar 2020
-
$3.71B(-37.0%)
Dec 2019
$17.73B(+6.5%)
$5.89B(+37.2%)
Sep 2019
-
$4.30B(+0.7%)
Jun 2019
-
$4.27B(+30.7%)
Mar 2019
-
$3.27B(-51.8%)
Dec 2018
$16.64B(+3.4%)
$6.77B(+106.7%)
Sep 2018
-
$3.27B(-3.1%)
Jun 2018
-
$3.38B(+1.0%)
Mar 2018
-
$3.35B(-30.7%)
Dec 2017
$16.09B(+5.2%)
$4.83B(+26.1%)
Sep 2017
-
$3.83B(+20.7%)
Jun 2017
-
$3.18B(-11.6%)
Mar 2017
-
$3.59B(+83.5%)
Dec 2016
$15.30B(-9.9%)
$1.96B(-48.1%)
Sep 2016
-
$3.77B(-11.0%)
Jun 2016
-
$4.24B(+4.1%)
Mar 2016
-
$4.07B(-20.0%)
Dec 2015
$17.00B(-7.2%)
$5.09B(+36.3%)
Sep 2015
-
$3.73B(-13.5%)
Jun 2015
-
$4.32B(+12.0%)
Mar 2015
-
$3.85B(-16.5%)
Dec 2014
$18.32B(+8.7%)
$4.62B(-0.8%)
Sep 2014
-
$4.65B(+7.1%)
Jun 2014
-
$4.35B(+4.2%)
Mar 2014
-
$4.17B(-31.7%)
Dec 2013
$16.85B(+14.6%)
$6.10B(+84.6%)
Sep 2013
-
$3.31B(-11.0%)
Jun 2013
-
$3.71B(-0.2%)
Mar 2013
-
$3.72B(-11.0%)
Dec 2012
$14.70B(-9.8%)
$4.18B(+28.6%)
Sep 2012
-
$3.25B(-5.6%)
Jun 2012
-
$3.45B(-9.6%)
Mar 2012
-
$3.81B(-40.3%)
Dec 2011
$16.29B(+6.3%)
$6.39B(+171.1%)
Sep 2011
-
$2.36B(-40.8%)
Jun 2011
-
$3.98B(+12.1%)
Mar 2011
-
$3.55B(-19.1%)
DateAnnualQuarterly
Dec 2010
$15.33B(-4.4%)
$4.39B(+10.6%)
Sep 2010
-
$3.97B(+7.5%)
Jun 2010
-
$3.69B(+12.6%)
Mar 2010
-
$3.28B(-40.5%)
Dec 2009
$16.04B(+1.1%)
$5.51B(+47.5%)
Sep 2009
-
$3.73B(+2.5%)
Jun 2009
-
$3.64B(+15.5%)
Mar 2009
-
$3.15B(-29.0%)
Dec 2008
$15.86B(+5.4%)
$4.45B(+21.5%)
Sep 2008
-
$3.66B(-6.7%)
Jun 2008
-
$3.92B(+2.3%)
Mar 2008
-
$3.83B(-18.5%)
Dec 2007
$15.05B(+18.5%)
$4.70B(+31.5%)
Sep 2007
-
$3.58B(+3.5%)
Jun 2007
-
$3.46B(+4.4%)
Mar 2007
-
$3.31B(-7.4%)
Dec 2006
$12.70B(+5.0%)
$3.57B(+16.3%)
Sep 2006
-
$3.07B(-2.7%)
Jun 2006
-
$3.16B(+8.9%)
Mar 2006
-
$2.90B(-11.1%)
Dec 2005
$12.09B(+3.5%)
$3.26B(+14.5%)
Sep 2005
-
$2.85B(-8.1%)
Jun 2005
-
$3.10B(+7.7%)
Mar 2005
-
$2.88B(-5.0%)
Dec 2004
$11.69B(+12.6%)
$3.03B(+7.9%)
Sep 2004
-
$2.81B(-6.0%)
Jun 2004
-
$2.98B(+4.2%)
Mar 2004
-
$2.86B(-7.0%)
Dec 2003
$10.38B(+11.4%)
$3.08B(+22.5%)
Sep 2003
-
$2.51B(+2.4%)
Jun 2003
-
$2.45B(+5.3%)
Mar 2003
-
$2.33B(-20.6%)
Dec 2002
$9.31B(+18.4%)
$2.94B(+31.5%)
Sep 2002
-
$2.23B(+2.1%)
Jun 2002
-
$2.19B(+11.9%)
Mar 2002
-
$1.96B(-8.8%)
Dec 2001
$7.87B(-42.3%)
$2.14B(+14.6%)
Sep 2001
-
$1.87B(-8.6%)
Jun 2001
-
$2.05B(+8.8%)
Mar 2001
-
$1.88B(-76.0%)
Dec 2000
$13.64B(+61.3%)
$7.83B(+311.9%)
Sep 2000
-
$1.90B(-4.4%)
Jun 2000
-
$1.99B(+3.3%)
Mar 2000
-
$1.92B(+11.4%)
Dec 1999
$8.46B(+23.3%)
$1.73B(-18.4%)
Sep 1999
-
$2.12B(-8.1%)
Jun 1999
-
$2.31B(+37.2%)
Dec 1998
$6.86B(+1.3%)
-
Jun 1998
-
$1.68B(+143.3%)
Dec 1997
$6.77B(-7.4%)
-
Dec 1996
$7.32B(+24.3%)
-
Dec 1995
$5.89B(+1.3%)
-
Jun 1995
-
$690.40M
Dec 1994
$5.81B(+4.7%)
-
Dec 1993
$5.55B(+9.0%)
-
Dec 1992
$5.09B(-16.3%)
-
Dec 1991
$6.08B(+0.7%)
-
Dec 1990
$6.04B
-

FAQ

  • What is AstraZeneca annual total operating expenses?
  • What is the all time high annual operating expenses for AstraZeneca?
  • What is AstraZeneca annual operating expenses year-on-year change?
  • What is AstraZeneca quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for AstraZeneca?
  • What is AstraZeneca quarterly operating expenses year-on-year change?

What is AstraZeneca annual total operating expenses?

The current annual operating expenses of AZN is $33.86B

What is the all time high annual operating expenses for AstraZeneca?

AstraZeneca all-time high annual total operating expenses is $33.86B

What is AstraZeneca annual operating expenses year-on-year change?

Over the past year, AZN annual total operating expenses has changed by +$5.04B (+17.49%)

What is AstraZeneca quarterly total operating expenses?

The current quarterly operating expenses of AZN is $7.67B

What is the all time high quarterly operating expenses for AstraZeneca?

AstraZeneca all-time high quarterly total operating expenses is $10.13B

What is AstraZeneca quarterly operating expenses year-on-year change?

Over the past year, AZN quarterly total operating expenses has changed by +$327.00M (+4.45%)
On this page